- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,054,674
- Total 13F shares
- 9,319,042
- Share change
- -906,912
- Total reported value
- $25,248,000
- Price per share
- $2.71
- Number of holders
- 25
- Value change
- -$3,677,975
- Number of buys
- 14
- Number of sells
- 9
Quarterly Holders Quick Answers
What is CUSIP 50127T109?
CUSIP 50127T109 identifies KURA - Kura Oncology, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 50127T109:
Top shareholders of KURA - Kura Oncology, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| FMR LLC |
13F
|
Company |
3.6%
|
3,097,354
|
$12,544,000 | — | 31 Mar 2016 | |
| EcoR1 Capital, LLC |
13F
|
Company |
2.8%
|
2,465,286
|
$9,984,000 | — | 31 Mar 2016 | |
| PFM Health Sciences, LP |
13F
|
Company |
1.8%
|
1,541,952
|
$6,245,000 | — | 31 Mar 2016 | |
| CLOUGH CAPITAL PARTNERS L P |
13F
|
Company |
1.2%
|
1,067,133
|
$4,322,000 | — | 31 Mar 2016 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.84%
|
730,500
|
$2,959,000 | — | 31 Mar 2016 | |
| Boxer Capital, LLC |
13F
|
Company |
0.74%
|
645,685
|
$2,615,000 | — | 31 Mar 2016 | |
| VANGUARD GROUP INC |
13F
|
Company |
0.34%
|
294,166
|
$1,191,000 | — | 31 Mar 2016 | |
| Birchview Capital, LP |
13F
|
Company |
0.09%
|
79,114
|
$320,000 | — | 31 Mar 2016 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.07%
|
63,000
|
$255,000 | — | 31 Mar 2016 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.03%
|
23,500
|
$95,000 | — | 31 Mar 2016 | |
| Partner Investment Management, L.P. |
13F
|
Company |
0.02%
|
20,022
|
$81,000 | — | 31 Mar 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.01%
|
12,781
|
$52,000 | — | 31 Mar 2016 | |
| CITIGROUP INC |
13F
|
Company |
0%
|
3,950
|
$16,000 | — | 31 Mar 2016 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0%
|
1,263
|
$5,000 | — | 31 Mar 2016 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0%
|
1,244
|
$5,000 | — | 31 Mar 2016 | |
| BlackRock Japan Co. Ltd |
13F
|
Company |
0%
|
1,224
|
$5,000 | — | 31 Mar 2016 | |
| UBS Group AG |
13F
|
Company |
0%
|
1,184
|
$5,000 | — | 31 Mar 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
0%
|
1,090
|
$4,000 | — | 31 Mar 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0%
|
904
|
$3,000 | — | 31 Mar 2016 |
Institutional Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q2 2016
As of 30 Jun 2016,
Kura Oncology, Inc. - Common Stock (KURA) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
9,319,042 shares.
The largest 10 holders included
FMR LLC, EcoR1 Capital, LLC, Partner Fund Management, L.P., Clough Capital Partners L P, Boxer Capital, LLC, Minerva Advisors LLC, VANGUARD GROUP INC, BRIDGEWAY CAPITAL MANAGEMENT INC, Alethea Capital Management, LLC, and Birchview Capital, LP.
This page lists
25
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
20
Q2 2016 holders
25
Holder diff
5
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.